Circulating Angiopoietin-2 Is a Marker for Early Cardiovascular Disease in Children on Chronic Dialysis

• Rukshana C. Shroff,

  Affiliation Nephro-Urology Unit, UCL Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom

  ⨯
• Karen L. Price,

  Affiliation Nephro-Urology Unit, UCL Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom

  ⨯
• Maria Kolatsi-Joannou,

  Affiliation Nephro-Urology Unit, UCL Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom

  ⨯
• Alexandra F. Todd,

  Affiliation Nephro-Urology Unit, UCL Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom

  ⨯
• David Wells,

  Affiliation Department of Chemical Pathology, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom

  ⨯
• John Deanfield,

  Affiliation National Centre for Cardiovascular Disease Prevention and Outcomes, University College London, London, United Kingdom

  ⨯
• Richard J. Johnson,

  Affiliation Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado, United States of America

  ⨯
• Lesley Rees,

  Affiliation Nephro-Urology Unit, UCL Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom

  ⨯
• Adrian S. Woolf,

  Affiliation Institute of Human Development, University of Manchester and the Royal Manchester Children’s Hospital, Manchester, United Kingdom

  ⨯
• David A. Long

  * E-mail: d.long@ucl.ac.uk

  Affiliation Nephro-Urology Unit, UCL Institute of Child Health and Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom

  ⨯